◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › SNGX

Soligenix, Inc. (SNGX) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Biotechnology · DATA UPDATED 2026-07-09

Soligenix, Inc. (SNGX) operates in the Biotechnology industry and is headquartered in Princeton, United States with about 13 employees. Its market capitalization is roughly $5 million. In the fiscal year ended 2025-12-31, SNGX reported $0M in revenue and ($11M) in net income.

Soligenix, Inc., a late-stage biopharmaceutical company, focuses on the development and commercialization of products to treat rare diseases in the United States. The company operates through two segments, Specialized BioTherapeutics and Public Health Solutions.

Interactive charts & full statements →

SNGX Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Revenue$0M$0M$0M$0M
Gross Profit$0M($0M)($1M)($0M)
Operating Income (EBIT)($12M)($10M)($8M)($14M)
Net Income($11M)($8M)($6M)($14M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNGX Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-31
Total Revenue$0M$0M$0M$0M$0M
Gross Profit$0M$0M$0M$0M$0M
Operating Income (EBIT)($3M)($4M)($3M)($3M)($3M)
Net Income($3M)($3M)($2M)($3M)($3M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SNGX Free Cash Flow History

SNGX Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total Assets$9M$9M$10M$14M
Total Liabilities$4M$5M$7M$17M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SNGX viewer.

Other Companies in Biotechnology

← SNFCAAll stocksSNN →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.